These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3936957

  • 21. Cold-restraint- and TRH-induced ulcer models demonstrate different biochemical and morphological manifestations in gastric and hepatic tissues in rats. Role of calcitonin.
    Erin N, Okar I, Oktay S, Ercan F, Arbak S, Yeğen BC.
    Dig Dis Sci; 1996 Jan; 41(1):55-64. PubMed ID: 8565767
    [Abstract] [Full Text] [Related]

  • 22. Hypothalamic somatostatin mediates the suppression of growth hormone secretion by centrally administered thyrotropin-releasing hormone in conscious rats.
    Katakami H, Arimura A, Frohman LA.
    Endocrinology; 1985 Sep; 117(3):1139-44. PubMed ID: 2862016
    [Abstract] [Full Text] [Related]

  • 23. Enhancement of gastric acid output and mucosal blood flow by tripeptide thyrotropin releasing hormone microinjected into the dorsal motor nucleus of the vagus in rats.
    Okuma Y, Osumi Y, Ishikawa T, Mitsuma T.
    Jpn J Pharmacol; 1987 Feb; 43(2):173-8. PubMed ID: 3106685
    [Abstract] [Full Text] [Related]

  • 24. Mechanisms underlying intracisternal TRH-induced stimulation of gastric acid secretion in rats.
    Taché Y, Goto Y, Hamel D, Pekary A, Novin D.
    Regul Pept; 1985 Dec; 13(1):21-30. PubMed ID: 3937184
    [Abstract] [Full Text] [Related]

  • 25. Calcitonin gene-related peptide: potent peripheral inhibitor of gastric acid secretion in rats and dogs.
    Taché Y, Pappas T, Lauffenburger M, Goto Y, Walsh JH, Debas H.
    Gastroenterology; 1984 Aug; 87(2):344-9. PubMed ID: 6145652
    [Abstract] [Full Text] [Related]

  • 26. Effect of luminal administration of thyrotropin-releasing hormone or somatostatin on gastric pH and interaction of these peptides in rats.
    Furusawa A, Morise K, Maeda Y, Uchida K, Kaneko H, Nakada K, Mitsuma T.
    Gastroenterol Jpn; 1992 Apr; 27(2):165-71. PubMed ID: 1349541
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of gastric acid secretion by immunoneutralization of endogenous brain thyrotropin-releasing hormone.
    Hernandez DE, Jennes L, Emerick SG.
    Brain Res; 1987 Jan 20; 401(2):381-4. PubMed ID: 2880645
    [Abstract] [Full Text] [Related]

  • 28. Involvement of vagal pathway in the anti-secretory effect of a novel xanthine derivative.
    Tanaka T, Taché Y, Guth PH.
    Eur J Pharmacol; 1993 Oct 26; 243(3):221-5. PubMed ID: 8276073
    [Abstract] [Full Text] [Related]

  • 29. Effect of bombesin, dermorphin and salmon calcitonin on gastric acid secretion in rats.
    Guglietta A, Irons BJ, Lazarus LH.
    Methods Find Exp Clin Pharmacol; 1988 Aug 26; 10(8):481-5. PubMed ID: 3226218
    [Abstract] [Full Text] [Related]

  • 30. Central nervous system action of TRH to stimulate gastric function and ulceration.
    Taché Y, Maeda-Hagiwara M, Goto Y, Garrick T.
    Peptides; 1988 Aug 26; 9 Suppl 1():9-13. PubMed ID: 2856654
    [Abstract] [Full Text] [Related]

  • 31. [Comparative effects of various centrally acting gastric secretagogues including PCPGABA and TRH in the perfused rat stomach preparation].
    Yamasaki K, Goto Y.
    Nihon Yakurigaku Zasshi; 1990 Jul 26; 96(1):11-21. PubMed ID: 2170251
    [Abstract] [Full Text] [Related]

  • 32. Intracisternal injection of a TRH analogue stimulates gastric luminal serotonin release in rats.
    Stephens RL, Tache Y.
    Am J Physiol; 1989 Feb 26; 256(2 Pt 1):G377-83. PubMed ID: 2493198
    [Abstract] [Full Text] [Related]

  • 33. Gastric hypersecretion by intracisternal TRH: dissociation from hypophysiotropic activity and role of central catecholamine.
    Taché Y, Lesiege D, Vale W, Collu R.
    Eur J Pharmacol; 1985 Jan 02; 107(2):149-55. PubMed ID: 3920055
    [Abstract] [Full Text] [Related]

  • 34. Thyrotropin-releasing hormone: medullary site of action to induce gastric ulcers and stimulate acid secretion.
    Hernandez DE, Emerick SG.
    Brain Res; 1988 Aug 30; 459(1):148-52. PubMed ID: 3139260
    [Abstract] [Full Text] [Related]

  • 35. The protective effect of 5-HT3 receptor antagonist in thyrotropin releasing hormone-induced gastric lesions.
    Erin N, Yegen BC, Oktay S.
    Peptides; 1997 Aug 30; 18(6):893-8. PubMed ID: 9285940
    [Abstract] [Full Text] [Related]

  • 36. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production.
    Judd AM, Kubota T, Kuan SI, Jarvis WD, Spangelo BL, Macleod RM.
    Endocrinology; 1990 Jul 30; 127(1):191-9. PubMed ID: 2163310
    [Abstract] [Full Text] [Related]

  • 37. Intraventricular calcitonin inhibits gastric acid secretion.
    Morley JE, Levine AS, Silvis SE.
    Science; 1981 Nov 06; 214(4521):671-3. PubMed ID: 7292006
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Synthetic eel calcitonin stimulates thyrotropin releasing hormone release from rat stomach in vitro.
    Mitsuma T, Hirooka Y, Nogimori T.
    Endocrinol Exp; 1988 Sep 06; 22(3):159-63. PubMed ID: 3146500
    [Abstract] [Full Text] [Related]

  • 40. Intracerebroventricular administration of human calcitonin and human calcitonin gene-related peptide inhibits meal-stimulated gastric acid secretion in the dog.
    Lenz HJ, Brown MR.
    Dig Dis Sci; 1987 Apr 06; 32(4):409-16. PubMed ID: 3493890
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.